MoneyWorks4Me

Dr Reddys Laboratories informs about disclosure

17 May 2025 Evaluate
Dr Reddys Laboratories has informed that the United States Food & Drug Administration (USFDA) completed a GMP inspection at its API Middleburgh facility in New York. The inspection was conducted from 12th May, 2025 to 16th May, 2025 (US EST time). They have been issued a Form 483 with 2 observations, which they will address within the stipulated timeline. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..